John Abramson

Date: 2021-12-30 | Duration: 2h 33m

Category: Health & Medicine, Politics & Media

Episode Overview

John Abramson delivers a critical examination of the pharmaceutical industry’s influence on American healthcare, focusing on how drug companies manipulate science and marketing to maximize profits at the expense of patients. He discusses the deceptive advertising tactics used to promote medications like Trulicity and the notorious painkiller Vioxx, revealing how clinical trial data is often selectively presented to exaggerate benefits and downplay risks. Abramson highlights the tragic consequences of these practices, including thousands of preventable deaths, and critiques the lack of accountability despite massive fines paid by drug companies. The conversation also delves into the challenges doctors face navigating a system overwhelmed by biased information and financial pressures. Abramson emphasizes the importance of evidence-based medicine and transparency in clinical data to restore trust and improve patient outcomes. He touches on the complexities surrounding COVID-19 treatments and vaccines, addressing controversies like ivermectin use and the politicization of public health measures. Finally, Abramson advocates for systemic reforms, including better regulation of drug pricing, improved medical education, and stronger community health initiatives focused on lifestyle changes to combat chronic diseases. His insights paint a sobering picture of a healthcare system in crisis but offer a roadmap toward more ethical and effective care.

About John Abramson

John Abramson, MD, is a distinguished lecturer at Harvard Medical School and a leading expert in national drug litigation, renowned for his critical insights into the intersection of healthcare and pharmaceutical practices. He is the author of the highly anticipated book, "Sickening: How Big Pharma Broke American Health Care and How We Can Repair It," set to release on February 8, which delves into the complexities of the American healthcare system and the pervasive influence of the pharmaceutical industry. With a career dedicated to uncovering the truths behind drug efficacy and healthcare policies, Abramson's work challenges conventional narratives and aims to empower consumers and policymakers alike. His expertise and thought-provoking perspectives make him a compelling voice in the ongoing discourse about healthcare reform.

Key Moments

– Pharmaceutical Advertising
– Drug Marketing Strategies
– Evidence-Based Medicine
– Clinical Trial Manipulation
– Drug Pricing and Cost Effectiveness
– Vioxx Controversy
– COVID-19 Treatments
– Ivermectin Debate
– Healthcare System Flaws
– Insulin Pricing
– Opioid Epidemic
– Medical Misinformation
– Regulation and Oversight
– Lifestyle and Disease Prevention
– Drug Company Profits
– Patient Trust in Medicine
– Public Health Policy
– Genetic Engineering of Drugs
0:00:28 – Introduction to the subject of the book
0:02:01 – Impact of advertising money on drug perception
0:03:45 – Claims about Trulicity and cardiovascular prevention
0:06:23 – Ethics of drug advertising to vulnerable patients
0:07:06 – Proposals for accurate drug advertisement regulation
0:10:25 – Acknowledging benefits of pharmaceutical drugs
0:13:04 – Marketing exploitation of scientific data
0:15:45 – Doctors' reliance on peer-reviewed articles
0:17:27 – Pharmaceutical companies' data manipulation tactics
0:19:48 – Exclusion of cost effectiveness in US drug policy
0:22:33 – Personal story of Vioxx-related child death
0:25:46 – Vioxx withdrawal following book publication
0:28:27 – Lack of legal consequences for drug fraud
0:35:31 – Misleading doctors in Kaiser health system
0:36:51 – Pfizer's misleading COVID-19 drug trial
0:38:55 – Controversy around ivermectin use
0:41:19 – Ivermectin as a generic drug debate
0:44:30 – Supply versus distribution issues in drug availability
0:46:05 – Vaccination messaging and Omicron variant
0:51:43 – Lecture promoting withdrawn pain drug
0:56:15 – Critique of vaccine effectiveness claims
0:58:36 – COVID-19 daily death toll in the US
1:03:25 – Second-line versus first-line drug use in diabetes
1:15:21 – Pill mills and opioid crisis in Florida
1:18:07 – Fentanyl overdose deaths in young adults
1:21:15 – Need for authoritative health regulation center
1:25:02 – Challenges in insulin pricing and cost containment
1:29:43 – Pharma stock buybacks and profit focus
1:33:18 – Public cases exposing pharmaceutical misconduct
1:35:50 – Global funding for drug access in poor countries
1:39:42 – Merck's ivermectin donation to Africa
1:43:15 – Limitations of ivermectin clinical trials
1:45:27 – Lifestyle as best approach to health improvement
1:49:56 – Community gyms and group exercise benefits
1:52:16 – Big pharma influence on diabetes treatment
1:58:53 – Plan to limit insulin prices
2:04:16 – Need for transparency in clinical trial data
2:12:46 – Drugs reducing amyloid but not improving Alzheimer's
2:15:05 – Building coalitions for healthcare reform
2:23:58 – Vaccination considerations for children

Transcript Excerpt

Starting point is 00:00:00 Joe Rogan Podcast, check it out! Starting point is 00:00:28 And this is the subject of your book. Starting point is 00:00:40 I tried to get it. Starting point is 00:01:08 Well, let's start with that question. Yeah, let's do that. Starting point is 00:02:01 Because then the amount of money that's involved in advertising, Starting point is 00:02:56 There's no beneficial use of those. Starting point is 00:03:45 that. They tell you trulicity for diabetes prevents cardiovascular events in diabetics. Starting point is 00:04:42 How much does it cost? How many people do you need Starting point is 00:05:31 or whatever it is. Starting point is 00:05:48 They're clearly fucking with people's heads and they're using psychology. Starting point is 00:06:23 If you want to do that to sell a car it doesn't bother me at all but you're doing something that you people who have health problems Starting point is 00:07:06 But I think we could make the drug ads. You could ensure that the drug ads leave people with an accurate understanding of what the benefit of the drug is going to be. Starting point is 00:07:54 Yeah, I'm totally with you. I just think that it's not going to happen that we get rid of them. Starting point is 00:09:00 be so bad. Starting point is 00:09:30 lifestyle choices, if you're talking about diet and exercise and how it affects the way these Starting point is 00:09:58 Yeah, yeah, yeah. Starting point is 00:10:25 drugs have some amazing benefits and they've been incredible for mankind in so many different ways. Starting point is 00:11:20 But as well, some pharmaceutical drugs are amazing. Starting point is 00:11:43 Their purpose is to make money. Starting point is 00:12:35 the lie? Like, what were they selling versus what was reality? So I can't tell you. I know, Starting point is 00:13:04 of the primary data, I got that. I got to see how the marketing people strategize to exploit the science to create Starting point is 00:14:00 And I did. And...

More Episodes

Frequently asked about this episode

Who was the guest on Joe Rogan Experience #1756?

John Abramson was the guest on JRE #1756. This page includes the episode overview, topics discussed, and related resources.

What topics were discussed on JRE #1756?

On Joe Rogan Experience #1756 with John Abramson, topics include Pharmaceutical Advertising, Drug Marketing Strategies, Evidence-Based Medicine, and Clinical Trial Manipulation.

Where can I read the transcript for JRE #1756?

The full searchable transcript for Joe Rogan Experience #1756 with John Abramson is available on this page, along with key topics and timestamps.